Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312 Hold
127
﹤0.01% 3680
2026
Q1
$199 Buy
+127
New +$229 ﹤0.01% 3779
2025
Q1
Sell
-124,021
Closed -$439K 2684
2024
Q4
$439K Sell
124,021
-4,181
-3% -$16.5K ﹤0.01% 2573
2024
Q3
$542K Sell
128,202
-15,434
-11% -$66.7K ﹤0.01% 2621
2024
Q2
$539K Buy
143,636
+63,731
+80% +$290K ﹤0.01% 2608
2024
Q1
$433K Hold
79,905
﹤0.01% 2325
2023
Q4
$493K Buy
79,905
+12,200
+18% +$60K ﹤0.01% 2324
2023
Q3
$351K Buy
67,705
+11,000
+19% +$58.7K ﹤0.01% 2395
2023
Q2
$209K Hold
56,705
﹤0.01% 2563
2023
Q1
$209K Buy
+56,705
New +$214K ﹤0.01% 2563

Other funds holding OABI

UBS AM's OABI Position: Q2 2026 in Review

UBS AM held its OmniAb (OABI) position steady in Q2 2026 at 127 shares worth $312. The position accounts for ﹤0.01% of the portfolio, ranked #3680.

UBS AM first reported a position in OABI in Q1 2023 and has held it in 10 quarters since. The position peaked at $542K in Q3 2024. 131 funds tracked by Wall St. Rank hold OABI as of Q2 2026.

  • UBS AM held 127 shares of OmniAb worth $312 as of Q2 2026.
  • UBS AM left its OmniAb share count unchanged in Q2 2026.
  • OmniAb made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3680 holding.
  • UBS AM first reported a position in OmniAb in Q1 2023 and has held it in 10 quarters since.
  • UBS AM's OmniAb position peaked at $542K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held OmniAb as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.